Complejo Hospitalario de Pontevedra - Hospital de Montecelo
- Address
- C/ Mourente, s/n, 36004 Pontevedra, Spain
Complejo Hospitalario de Pontevedra - Hospital de Montecelo
The Complejo Hospitalario de Pontevedra - Hospital de Montecelo serves as an active research facility conducting clinical trials across diverse therapeutic areas. The center demonstrates expertise in investigating novel therapeutic interventions for metabolic liver disorders and inner ear pathologies, contributing to advancement in treatment options for conditions with significant unmet medical needs.
- Non-alcoholic steatohepatitis (NASH) and hepatic fibrosis treatment with combination pharmacotherapy
- Menière's disease management and vestibular disorder therapeutics
- Comparative effectiveness research and pharmaceutical formulation optimization
The facility participates in multicenter trials evaluating both innovative combination therapies for metabolic liver disease and advanced drug delivery systems for vestibular disorders. Research activities include assessment of fibrosis regression in NASH patients using combination regimens and evaluation of prolonged-release formulations designed to improve treatment adherence and outcomes in chronic conditions such as Menière's disease, encompassing symptom control for vertigo, tinnitus, and hearing preservation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Intas Pharmaceuticals Limited1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Complejo Hospitalario de Pontevedra - Hospital de Montecelo
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease | Novo Nordisk A/S | Phase II | Not Recruiting | Aug 2024 | Jan 2026 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cagrilintide | 2 | Unknown | 2021-08-31 | 2024-08-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.